After bringing in one of the top venture capital investments during first quarter 2015, Neos Therapeutics has filed for an initial public offering. The Grand Prairie-based company, which develops medication for Attention Deficit/Hyperactivity Disorder, filed Friday to trade on the Nasdaq under ticker symbol NEOS.
Meet the talented individuals who brought their expertise and dedication to this project. Their collaboration, insight, and commitment to excellence were instrumental in delivering impactful results for our clients.
Stay updated with the latest industry news.
Stay updated with the latest industry news.
Whether you're seeking guidance on a complex transaction, exploring investment banking possibilities, or looking for wealth management strategies, our team is here to help.
Provide your email to join our distribution list. By providing your email you consent to receive emails from Salem Partners Wealth Management.